Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Pulmonary Embolism Market Size From 2025 to 2034?
In recent times, the size of the pulmonary embolism market has been expanding swiftly. It is projected to increase from $2.03 billion in 2024 to $2.26 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. Factors contributing to the growth observed in the historical period include anticoagulant therapies, research and clinical trials, increased awareness of pulmonary embolism, and vte prophylaxis.
The market size for pulmonary embolism is set to experience a swift escalation in the coming years, with projections estimating it to reach$3.62 billion by 2029, with a compound annual growth rate (CAGR) of 12.5%. The anticipated growth during the forecast period is likely due to novel treatment methods, advancements in telemedicine and remote monitoring, health equity efforts, and worldwide health initiatives. Key trends expected during the forecast period encompass the use of artificial intelligence in diagnosis, innovative anticoagulants, the widespread implementation of pulmonary embolism response teams, and an emphasis on patient-focused care.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp
What Are the Core Growth Drivers Propelling the Pulmonary Embolism Market Forward?
The growth of the pulmonary embolism market is anticipated to be driven by the surging prevalence of blood clots. A blood clot or thrombus, a mass that is either gel-like or semisolid, develops inside a blood vessel. These blood clots obstruct blood circulation to the lungs, significantly escalating the risk of pulmonary embolism. Typically, this blockage caused by blood clot occurs in the legs’ deep veins, thereby heightening the potential for pulmonary embolism. As an example, an article by Gavi, the Vaccine Alliance, an international body aimed at enhancing access to novel and seldom used vaccines for children, suggested in April 2022 that there was a 33-fold surge in the risk of potentially lethal lung clots and a five-fold hike in the threat of deep vein thrombosis within 30 days of exposure to COVID-19. Consequently, the rise in incidences of blood clots is fueling the expansion of the pulmonary embolism market.
What Segment Types Define the Pulmonary Embolism Market Structure?
The pulmonary embolismmarket covered in this report is segmented –
1) By Treatment: Medications; Mechanical Devices; Other Treatments
2) By Diagnosis: Chest X-Ray; Electrocardiogram (ECG); Magnetic Resonance Imaging (MRI); Computed Tomography Scan; Pulmonary Angiography; Venography; Venous Ultrasound; D-Dimer Test; Other Diagnosis
3) By Symptoms: Shortness Of Breath; Chest Pain; Cough; Irregular Heartbeat; Dizziness; Fever; Cyanosis; Other Symptoms
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medications: Anticoagulants; Thrombolytics
2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters; Catheter-Assisted Thrombectomy
3) By Other Treatments: Surgical Embolectomy; Supportive Care
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Pulmonary Embolism Market?
North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Emerging Trends that Are Influencing thePulmonary Embolism Industry Evolution?
The main corporations within the pulmonary embolism industry are committed to devising innovative products such as the Triever16 Curve catheter and the RevCore thrombectomy catheter to establish a competitive edge. Inari Medical Inc., a medical device firm based in the USA, for instance, in June 2023, rolled out the Triever16 Curve catheter and the RevCore thrombectomy catheter. The Triever16 Curve catheter, an inventive product, is designed predominantly for peripheral thrombectomy and pulmonary embolism procedures. It has enhanced trackability with a pre-shaped curve promoting targeted aspiration. The catheter is uniquely structured, facilitating access to larger and more potent 20F or 24F catheters, and the RevCore thrombectomy catheter is devised to manage venous in-stent thrombosis. This mechanical thrombectomy device employs a nitinol basket to capture and eliminate blood clots. These catheters, moreover, enhance the safety and efficiency of pulmonary embolism procedures.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report
What Is the Definition of the Pulmonary Embolism Market?
A pulmonary embolism is a blockage in the pulmonary artery, which transports blood from the heart to the lungs. It causes the clot of blood that has gone to the lungs from another area of the body, most commonly the legs, which causes blockage. The symptoms of pulmonary embolism might range from abrupt shortness of breath to chest pain, coughing up blood or bloody mucus and others, depending on the severity of the clot.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13026
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model